Literature DB >> 7968787

Primary thyroid carcinoma in children: a retrospective study of 20 patients.

M Massimino1, M Gasparini, E Ballerini, R Del Bo.   

Abstract

A total of 20 children (median age 11 years) were treated for primary thyroid carcinoma from 1976 to 1990. Papillary adenocarcinoma was diagnosed in 19 and follicular in one case. Nineteen of 20 patients were considered amenable to surgery, which consisted of total thyroidectomy in 14 and partial thyroidectomy in 5. Only one patient with extensive perithyroid soft tissue infiltration was treated with external beam radiotherapy. Monolateral or bilateral cervical nodal dissection was performed in eight and six children, respectively; in nine cases without clinical evidence of metastatic nodes. Pathological examination showed that tumor extent was greater than that clinically assessed: Multiple tumor foci within the thyroid were assessed in 8/19, unilateral positive nodes in 8, and bilateral in 6, and soft tissue infiltration in 7. Subsequently 10 patients received thyroid-stimulating hormone (TSH) suppressive hormonotherapy. Relapses occurred in 7/20 at 2-48 months (median 18) from primary treatment: Four in cervical nodes, two in cervical nodes and lungs, and one in lungs. These seven patients were salvaged with node dissection and radioiodine therapy for lung metastases. All the 20 children are alive and disease-free after a median follow-up of longer than 10 years. The incidence of relapse was greater in the group of patients not given TSH-suppressive hormonotherapy. Total thyroidectomy produced permanent hypoparathyroidism in 5/14 (36%). Thyroid carcinoma in children of this series frequently presented with multiple tumor foci within the thyroid and cervical node metastases. Prognosis was favourable even after relapse and was not related to the extent of surgical treatment. Limited surgery and suppressive hormonotherapy may be adequate therapy for thyroid carcinoma in children.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7968787     DOI: 10.1002/mpo.2950240104

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  7 in total

1.  Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.

Authors:  Ning Qu; Ling Zhang; Zhong-Wu Lu; Qing-Hai Ji; Shu-Wen Yang; Wen-Jun Wei; Yan Zhang
Journal:  Tumour Biol       Date:  2015-12-22

Review 2.  Common childhood thyroid disorders.

Authors:  D Dreimane; S K Varma
Journal:  Indian J Pediatr       Date:  1997 Jan-Feb       Impact factor: 1.967

3.  Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.

Authors:  Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

4.  Differentiated thyroid cancer.

Authors:  Ajay Kumar; C S Bal
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

5.  Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer.

Authors:  Fernanda Vaisman; Daniel Alves Bulzico; Cencita Hosannah Cordeiro Noronha Pessoa; Maria Alice Neves Bordallo; Ullyanov Bezerra Toscano de Mendonça; Fernando Luiz Dias; Claudia Medina Coeli; Rossana Corbo; Mario Vaisman
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at a Single Institution.

Authors:  Kwangsoon Kim; Cho Rok Lee; Sang-Wook Kang; Jandee Lee; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung
Journal:  World J Surg       Date:  2020-10       Impact factor: 3.352

7.  Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival.

Authors:  Nobuyuki Wada; Kiminori Sugino; Takashi Mimura; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Hirotaka Nakayama; Shohei Hirakawa; Yasushi Rino; Munetaka Masuda; Koichi Ito
Journal:  BMC Cancer       Date:  2009-09-01       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.